Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACTINIUM PHARMACEUTICALS, INC.

(ATNM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 44,835,9106182--
Entreprise Value (EV)1 31,435,9106182182182
P/E ratio -1,76x-1,45x-4,26x-7,64x-11,5x-31,3x
Yield ------
Capitalization / Revenue ---179x11,8x5,00x
EV / Revenue ---179x11,8x5,00x
EV / EBITDA -1,88x--5,06x-7,73x-4,76x-3,87x
Price to Book --2,23x2,57x1,88x2,45x
Nbr of stocks (in thousands) 3 8575 49013 58722 024--
Reference price (USD) 11,66,537,808,258,258,25
Announcement Date 03/15/201905/08/202003/31/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 ---1,0215,436,4
EBITDA1 -23,8--21,0-23,5-38,2-47,0
Operating profit (EBIT)1 -23,8-22,1-22,4-22,3-20,4-16,3
Operating Margin ----2 196%-133%-44,7%
Pre-Tax Profit (EBT)1 -23,7-21,9-22,2-22,3-17,7-9,43
Net income1 -23,7-21,9-22,2-22,3-17,7-6,00
Net margin ----2 194%-115%-16,5%
EPS2 -6,60-4,50-1,83-1,08-0,72-0,26
Dividend per Share ------
Announcement Date 03/15/201905/08/202003/31/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 -0,620,270,090,09-
EBITDA1 -5,33-5,25-4,95-6,30-6,70-
Operating profit (EBIT)1 -6,44-5,37-5,08-5,50-5,98-5,76
Operating Margin --864%-1 908%-5 891%-6 640%-
Pre-Tax Profit (EBT)1 -6,38-5,32-5,02-5,64-6,29-5,71
Net income1 -6,38-5,32-5,02-5,64-6,29-5,71
Net margin --855%-1 888%-6 047%-6 989%-
EPS2 -0,40-0,29-0,25-0,26-0,29-0,24
Dividend per Share ------
Announcement Date 03/31/202105/14/202107/30/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position 13,4-----
Leverage (Debt / EBITDA) 0,56x-----
Free Cash Flow1 -20,7--21,9-21,2-26,5-27,5
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 --3,503,214,383,37
Cash Flow per Share ------
Capex1 0,10-0,250,300,310,33
Capex / Sales ---29,0%2,02%0,89%
Announcement Date 03/15/201905/08/202003/31/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 181 699 377
Number of employees 32
Free-Float 98,6%
Free-Float capitalization (USD) 179 141 836
Avg. Exchange 20 sessions (USD) 2 349 777
Average Daily Capital Traded 1,29%
EPS & Dividend